Cargando…

Two‐dimensional in vivo dose verification using portal imaging and correlation ratios

The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Peca, Stefano, Brown, Derek W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875516/
https://www.ncbi.nlm.nih.gov/pubmed/25207402
http://dx.doi.org/10.1120/jacmp.v15i4.4752
_version_ 1783310360954011648
author Peca, Stefano
Brown, Derek W.
author_facet Peca, Stefano
Brown, Derek W.
author_sort Peca, Stefano
collection PubMed
description The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired during treatment) to calculate dose in the isocenter point. The extension allows calculation of two‐dimensional dose maps of the entire radiation field at the depth of isocenter. We quantified the variability of the ratio of EPID signal to dose in the isocenter plane in Solid Water phantoms of various thicknesses and with various field sizes, and designed a field edge dose calculation correction. To validate the method, we designed three realistic conventional radiation therapy treatment plans on a thorax and head anthropomorphic phantom (whole brain, brain primary, lung tumor). Using CT data, EPID transit images, EPID signal‐to‐dose correlation, and our edge correction, we calculated dose in the isocenter plane and compared it with the treatment planning system's prediction. Gamma evaluation (3%, 3 mm) showed good agreement (P(γ<1) ≥ 96.5%) for all fields of the whole brain and brain primary plans. In the presence of lung, however, our algorithm overestimated dose by 7%–9%. This 2D EPID‐based in vivo dosimetry method can be used for posttreatment dose verification, thereby improving the safety and quality of patient treatments. With future work, it may be extended to measure dose in real time and to prevent harmful delivery errors. PACS numbers: 87.55.km, 87.55.Qr, 87.55.T‐
format Online
Article
Text
id pubmed-5875516
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58755162018-04-02 Two‐dimensional in vivo dose verification using portal imaging and correlation ratios Peca, Stefano Brown, Derek W. J Appl Clin Med Phys Radiation Oncology Physics The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired during treatment) to calculate dose in the isocenter point. The extension allows calculation of two‐dimensional dose maps of the entire radiation field at the depth of isocenter. We quantified the variability of the ratio of EPID signal to dose in the isocenter plane in Solid Water phantoms of various thicknesses and with various field sizes, and designed a field edge dose calculation correction. To validate the method, we designed three realistic conventional radiation therapy treatment plans on a thorax and head anthropomorphic phantom (whole brain, brain primary, lung tumor). Using CT data, EPID transit images, EPID signal‐to‐dose correlation, and our edge correction, we calculated dose in the isocenter plane and compared it with the treatment planning system's prediction. Gamma evaluation (3%, 3 mm) showed good agreement (P(γ<1) ≥ 96.5%) for all fields of the whole brain and brain primary plans. In the presence of lung, however, our algorithm overestimated dose by 7%–9%. This 2D EPID‐based in vivo dosimetry method can be used for posttreatment dose verification, thereby improving the safety and quality of patient treatments. With future work, it may be extended to measure dose in real time and to prevent harmful delivery errors. PACS numbers: 87.55.km, 87.55.Qr, 87.55.T‐ John Wiley and Sons Inc. 2014-07-08 /pmc/articles/PMC5875516/ /pubmed/25207402 http://dx.doi.org/10.1120/jacmp.v15i4.4752 Text en © 2014 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Peca, Stefano
Brown, Derek W.
Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
title Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
title_full Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
title_fullStr Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
title_full_unstemmed Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
title_short Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
title_sort two‐dimensional in vivo dose verification using portal imaging and correlation ratios
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875516/
https://www.ncbi.nlm.nih.gov/pubmed/25207402
http://dx.doi.org/10.1120/jacmp.v15i4.4752
work_keys_str_mv AT pecastefano twodimensionalinvivodoseverificationusingportalimagingandcorrelationratios
AT brownderekw twodimensionalinvivodoseverificationusingportalimagingandcorrelationratios